Absci Corporation (ABSI)
ABSI Stock Price Chart
Explore Absci Corporation interactive price chart. Choose custom timeframes to analyze ABSI price movements and trends.
ABSI Company Profile
Discover essential business fundamentals and corporate details for Absci Corporation (ABSI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
22 Jul 2021
Employees
156.00
Website
https://www.absci.comCEO
Sean McClain
Description
Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.
ABSI Financial Timeline
Browse a chronological timeline of Absci Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Aug 2026
EPS estimate is -$0.15, while revenue estimate is $886.25k.
Earnings released on 7 May 2026
EPS came in at -$0.19 surpassing the estimated -$0.20 by +5.00%, while revenue for the quarter reached $215.00k , missing expectations by -82.89%.
Earnings released on 24 Mar 2026
EPS came in at -$0.23 falling short of the estimated -$0.16 by -43.75%, while revenue for the quarter reached $650.00k , missing expectations by -51.45%.
Earnings released on 12 Nov 2025
EPS came in at -$0.20 falling short of the estimated -$0.19 by -5.26%, while revenue for the quarter reached $378.00k , missing expectations by -72.63%.
Earnings released on 12 Aug 2025
EPS came in at -$0.24 falling short of the estimated -$0.19 by -26.32%, while revenue for the quarter reached $593.00k , missing expectations by -88.54%.
Earnings released on 13 May 2025
EPS came in at -$0.21 surpassing the estimated -$0.23 by +8.70%, while revenue for the quarter reached $1.18m , missing expectations by -9.31%.
Earnings released on 18 Mar 2025
EPS came in at -$0.25 falling short of the estimated -$0.22 by -13.64%, while revenue for the quarter reached $665.00k , missing expectations by -86.34%.
Earnings released on 12 Nov 2024
EPS came in at -$0.24 falling short of the estimated -$0.19 by -26.32%, while revenue for the quarter reached $1.70m , missing expectations by -5.79%.
Earnings released on 14 Aug 2024
EPS came in at -$0.22 falling short of the estimated -$0.19 by -15.79%, while revenue for the quarter reached $1.27m , missing expectations by -33.51%.
Earnings released on 14 May 2024
EPS came in at -$0.22 falling short of the estimated -$0.19 by -15.79%, while revenue for the quarter reached $898.00k , missing expectations by -62.89%.
Earnings released on 21 Mar 2024
EPS came in at -$0.25 falling short of the estimated -$0.23 by -8.70%, while revenue for the quarter reached $338.00k , missing expectations by -67.18%.
Earnings released on 14 Nov 2023
EPS came in at -$0.24 falling short of the estimated -$0.23 by -4.35%, while revenue for the quarter reached $744.00k , missing expectations by -66.03%.
Earnings released on 14 Aug 2023
EPS came in at -$0.27 falling short of the estimated -$0.24 by -12.50%, while revenue for the quarter reached $3.37m , beating expectations by +38.21%.
Earnings released on 15 May 2023
EPS came in at -$0.26 falling short of the estimated -$0.24 by -8.33%, while revenue for the quarter reached $1.27m , missing expectations by -43.52%.
Earnings released on 30 Mar 2023
EPS came in at -$0.21 surpassing the estimated -$0.24 by +12.50%, while revenue for the quarter reached $1.56m , missing expectations by -67.07%.
Earnings released on 9 Nov 2022
EPS came in at -$0.30 falling short of the estimated -$0.27 by -11.11%, while revenue for the quarter reached $2.37m , beating expectations by +26.46%.
Earnings released on 11 Aug 2022
EPS came in at -$0.32 matching the estimated -$0.32, while revenue for the quarter reached $1.00m , missing expectations by -38.17%.
Earnings released on 11 May 2022
EPS came in at -$0.33 falling short of the estimated -$0.29 by -13.79%, while revenue for the quarter reached $819.00k , missing expectations by -54.35%.
Earnings released on 22 Mar 2022
EPS came in at -$0.28 falling short of the estimated -$0.23 by -21.74%, while revenue for the quarter reached $1.45m , missing expectations by -14.23%.
Earnings released on 9 Nov 2021
EPS came in at -$0.28 falling short of the estimated -$0.21 by -33.33%, while revenue for the quarter reached $1.54m , missing expectations by -25.29%.
Earnings released on 7 Sept 2021
EPS came in at -$2.39 falling short of the estimated -$0.85 by -181.18%, while revenue for the quarter reached $728.00k .
Earnings released on 23 Jul 2021
EPS came in at -$0.12 , while revenue for the quarter reached $1.06m .
ABSI Stock Performance
Access detailed ABSI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
